ACTRN12622000662763尚未招募1 期
The feasibility and safety of autologous umbilical cord blood derived cell administration following antenatally diagnosed fetal stroke
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 5 Days 至 14 Days（—）
- 性别
- All
入选标准
- •Infants with brain injury associated with fetal stroke after confirmation of brain injury on postnatal imaging (Cranial ultrasound, MRI brain) soon after birth. Whilst there is no gestational age cut off, it is expected most infants will be born at or near term gestation.
排除标准
- •Infants who are likely to have redirection of care (palliation) for any reason.
研究者
相似试验
尚未招募
1 期
Safety and Efficacy of Umbilical Cord Blood Serum Derived Extracellular Vesicles versus for Treatment of Androgenic AlopeciaIRCT20221130056672N1Tehran University of Medical Sciences30
已完成
不适用
Feasibility and safety of Umbilical cord blood as a potential source for blood transfusion in neonates.CTRI/2016/12/007536Institute of Child Health and hospital for ChildrenDepartment of Neonatology200
已完成
1 期
A pilot feasibility and safety study of autologous umbilical cord blood cell therapy in infants with neonatal encephalopathyeonatal encephalopathy (Neonatal hypoxic-ischemic encephalopathy)JPRN-UMIN000014903eonatal Encephalopathy Consortium, Japan6
招募中
不适用
Allogeneic UCB Therapy With EPO in Children With CPDiseases of the nervous systemKCT0000950Bundang CHA General Hospital120
进行中（未招募）
2 期
Evaluate efficacy and safety of umbilical cord-derived mesenchymal stromal cells (HLC-001) for patient with Noninfectious lung complications after allogeneic haematopoietic stem cell transplantatioJPRN-jRCT2063220014Morio Ikeda12